CLSD – clearside biomedical, inc. (US:NASDAQ)
Stock Stats
News
Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye
Clearside Biomedical, Inc. (NASDAQ: CLSD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States
Wet Age-Related Macular Degeneration (Wet AMD) Pipeline Landscape Research 2024 [Yahoo! Finance]
Form 8-K Clearside Biomedical, For: Dec 12
Form 10-Q Clearside Biomedical, For: Sep 30
Form 8-K Clearside Biomedical, For: Nov 12
Form 4 Clearside Biomedical, For: Nov 01 Filed by: Chong Ngai Hang Victor
Form 8-K Clearside Biomedical, For: Oct 09
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.